Drug intelligence / Profile preview

Easy Transil NF

Development stage: Unknown
Lead developer: Astel Medica
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Easy Transil NF is a multi-ingredient dietary supplement developed by the Belgian company Astel Medica, specifically formulated to promote regular intestinal transit and address constipation. The product is delivered as an oral capsule and contains a combination of plant extracts (*Cassia fistula*, *Terminalia chebula*, *Rhamnus frangula*), spirulina algae, oat fiber, and beneficial probiotic bacteria. Its mechanism of action is primarily mechanical and biological: algae provide lubrication for the food bolus, fibers increase its volume, and plant extracts stimulate natural intestinal muscle contractions. Additionally, the probiotic component assists in the decomposition of the food bolus. Easy Transil NF is designed to act within 8 hours and is suitable for adults and children over 12 years of age. It is free from gluten, lactose, and added sugars.

Brand names: Easy Transil NF

Beyond the preview

Go deeper on Easy Transil NF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Easy Transil NF.

Explore the full profile